About Leucine Rich Bio
Leucine Rich Bio is a Healthcare company based in Bengaluru (India) founded in 2014. Genomics-based platforms for microbiome analysis are provided. Leucine Rich Bio has raised $483.8 thousand across 6 funding rounds from investors including Omphalos Ventures, Nitesh Aggarwal and Raghavendra Rao TS. The company has 17 employees. Leucine Rich Bio was last valued at $3.95 million in September 2023. Its Indian entity Leucine Rich Bio Private Limited reported revenue of ₹1.62 Cr. Its focus areas include Life Sciences, Genomics, Applied Genomics and Consumer Genomics.
Company details
Provider of the genomics-based platform to analyze microbiome. The Bugspeaks platform is used to analyze gut microbial sequencing data to provide personalized dietary and supplements recommendations. Other platforms are Metarich that is for cloud-based microbiome analysis, Rychbiome develops probiotics, prebiotics synbiotics based on the microbiome. The company is also developing two programs LRB120305 is formulations for specific diseases and LRB210814 for diagnostics. They provide services in the area of computer science, information science, data management, statistics, and systems biology to solve complex problems in genomics.
- Headquarters Bengaluru, India
- Employees 17
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Website leucinerichbio.com
- Social LinkedIn X Facebook
- Legal Name Leucine Rich Bio Private Limited
- Date of Incorporation 21 Aug, 2014
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹1.62 Cr
FY 2024 · +57% YoY
- Net Loss-₹54 Lakh
FY 2024 · -33% margin
- EBITDA-₹34.6 Lakh
FY 2024 · -21% margin
- Total Equity Funding$483.8K (USD)
in 6 rounds
- Latest Funding Round$59.21K (USD), Angel Round
Nov 2024
- InvestorsOmphalos Ventures
& 4 more
- Employee Count17
Associated legal entities of Leucine Rich Bio
Leucine Rich Bio operates through Leucine Rich Bio Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Leucine Rich Bio Private Limited CIN U72200KA2014PTC075922 | Active | 21 Aug 2014 | Bangalore, Karnataka | ₹1.6 Cr | 17 | 4 | View details |
Funding Insights of Leucine Rich Bio
Leucine Rich Bio has successfully raised a total of $483.8K across 6 strategic funding rounds. The most recent funding activity was a Angel Round of $59.21 thousand completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $483,802
- Total Rounds 6
- Last Round Angel Round — $59,208
- First Round $152,076
(Oct 2017)
- Investors Count 5
All 6 funding rounds of Leucine Rich Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2024 | $59,208 | Angel Round | – | Ashwin Porwal | |
| Sep 2023 | $48,298 | Seed | $3.95M | – | |
| Sep 2022 | Angel Round | – | Nitesh Aggarwal | – | |
| Oct 2019 | $70,391 | Angel Round | $3.81M | Raghavendra Rao TS | – |
| Apr 2018 | $153,829 | Seed | $••••• | Omphalos Ventures | – |
| Oct 2017 | $152,076 | Seed | $••••• | Omphalos Ventures | – |
| Date | Valuation | Stage |
|---|---|---|
| Sep 2023 | $3.95M | •••••••• |
| Oct 2019 | $3.81M | •••••••• |
| Apr 2018 | $••••• | •••••••• |
| Oct 2017 | $••••• | •••••••• |
Full valuation and stage history of Leucine Rich Bio
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $3.95M (Sep 2023). 5 investors in total: 1 institutional and 4 angel.
Investors in Leucine Rich Bio
Leucine Rich Bio has secured backing from 5 investors, including venture fund and angel investors. Prominent investors backing the company include Omphalos Ventures, Nitesh Aggarwal and Raghavendra Rao TS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investments are made by Omphalos Ventures in US firms. | omphalosventures.net | Shakopee, United States | ||
NA Nitesh Aggarwal | unknown_f5a133f1b1194b188 | |||
RR Raghavendra Rao TS | unknown_a5beb572537a4c048 | |||
AP Ashwin Porwal | unknown_9d4c596bf6d6466d8 | |||
SP Snehal Porwal | unknown_6fa25a34780645d78 |
Investor details for Leucine Rich Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Leucine Rich Bio Private Limited (Leucine Rich Bio)
Leucine Rich Bio Private Limited is the primary company behind Leucine Rich Bio. The board of Leucine Rich Bio Private Limited currently have 4 directors; the longest-serving is Prabhath Manjappa Kamath, appointed in 2014. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Prabhath Manjappa Kamath DIN 06836130 | Director | 21 Aug 2014 | 12 yrs 2 mo | Leucine Rich Bio Private Limited |
| Kumar Sankaran DIN 06895658 | Director | 21 Aug 2014 | 12 yrs 2 mo | Leucine Rich Bio Private Limited |
| Debojyoti Dhar DIN 07286366 | Director | 30 Sep 2015 | 11 yrs 1 mo | Leucine Rich Bio Private Limited |
| Naveen Chava DIN 03517306 | Director | 01 Aug 2024 | 2 yrs 3 mo | Leucine Rich Bio Private Limited |
Financials of Leucine Rich Bio
Figures of Leucine Rich Bio Private Limited, the primary company behind Leucine Rich Bio, for FY 2024. Revenue was ₹1.62 Cr (+57% year on year). Net loss was -₹54 Lakh (-33% margin). EBITDA was -₹34.6 Lakh (-21% margin). Revenue has grown at a compounded annual rate of +51% over three years and +25% over five years.
- ₹1.62 CrRevenue · FY 2024 · +57% YoY
- -₹54 LakhNet loss · -33% margin
- -₹34.6 LakhEBITDA · -21% margin
- ₹1.4 LakhPaid-up capital
- 17Employees (provident fund records)
- +51%Revenue CAGR, 3 years
- +25%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Leucine Rich Bio Private Limited are on its company page.
Detailed financial statements for Leucine Rich Bio
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Leucine Rich Bio
4 dated milestones of Leucine Rich Bio across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Leucine Rich Bio is founded.
- Funding First funding round of $152K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Angel Round, of $59K.
Web traffic of Leucine Rich Bio
The website of Leucine Rich Bio (leucinerichbio.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▲ 117.4% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Leucine Rich Bio
Complete news archive for Leucine Rich Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Leucine Rich Bio
Leucine Rich Bio was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Leucine Rich Bio is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Leucine Rich Bio is a funded company, having raised a total of $483.8K across 6 funding rounds to date. The company's 1st funding round was a Seed of $152.08K, raised on Oct 2017.
Leucine Rich Bio has 17 employees.
The primary company behind Leucine Rich Bio, Leucine Rich Bio Private Limited, reported revenue of ₹1.62 Cr for FY 2024, up 57% year on year.
Provider of the genomics-based platform to analyze microbiome. The Bugspeaks platform is used to analyze gut microbial sequencing data to provide personalized dietary and supplements recommendations. Other platforms are Metarich that is for cloud-based microbiome analysis, Rychbiome develops probiotics, prebiotics synbiotics based on the microbiome. The company is also developing two programs LRB120305 is formulations for specific diseases and LRB210814 for diagnostics. They provide services in the area of computer science, information science, data management, statistics, and systems biology to solve complex problems in genomics.
Leucine Rich Bio has 5 investors. Key investors include Omphalos Ventures, Nitesh Aggarwal, Raghavendra Rao TS, Ashwin Porwal, and Snehal Porwal.
The valuation of Leucine Rich Bio is $3.95M as of Sep 2023.
Leucine Rich Bio operates through Leucine Rich Bio Private Limited.
The legal entities of Leucine Rich Bio currently have 4 directors, including Naveen Chava, Prabhath Manjappa Kamath, Debojyoti Dhar and others.